HemoTreat is the newest and most innovative OTC Hemorrhoid solution available worldwide. Its unique European patented formula is a blend of ingredients specifically combined not only to provide short term, safe, effective relief but also lasting results. The real difference is that HemoTreat addresses the cause of the problem while alleviating the uncomfortable symptoms.
| Website | http://www.hemotreat.com |
| Revenue | $2 million |
| Employees | 1 (0 on RocketReach) |
| Founded | 2013 |
| Address | 1395 Brickell ave, Miami, Florida 33131, US |
| Phone | +1 305-809-7885 |
| Industry | Pharmaceutical Manufacturing, Manufacturing General, Manufacturing |
| Keywords | Hemorrhoid Treatment |
| Competitors | HemoGenyx LLC, Cerus, ADMA Biologics, Inc., Baxter International Inc., Blood Systems Inc. - Deactivated Site, BioLife Plasma Services, Octapharma, Grifols, CSL Behring, Kedrion Biopharma +40 more (view full list) |
| SIC | SIC Code 283 Companies, SIC Code 28 Companies |
| NAICS | NAICS Code 325 Companies, NAICS Code 3254 Companies, NAICS Code 32541 Companies, NAICS Code 32 Companies |
Looking for a particular HemoTreat employee's phone or email?
HemoTreat Questions
The HemoTreat annual revenue was $2 million in 2026.
HemoTreat is based in Miami, Florida.
The NAICS codes for HemoTreat are [325, 3254, 32541, 32].
The SIC codes for HemoTreat are [283, 28].
Related Companies
